Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000588240 | SCV000601254 | likely benign | not provided | 2022-07-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000588240 | SCV001020239 | likely benign | not provided | 2023-12-21 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000507965 | SCV001338232 | likely benign | not specified | 2020-02-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003159640 | SCV003855118 | likely benign | Inborn genetic diseases | 2023-01-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001276402 | SCV001462664 | likely benign | beta Thalassemia | 2020-04-16 | no assertion criteria provided | clinical testing |